Home » Topics » Disease categories and therapies » Infection

Infection
RSS

In vitro activity of novel pneumocandin antifungal agent

July 11, 1997

Lupulon for the treatment of MRSA

July 10, 1997

Transcell and Merck & Co. collaborate on antibacterial research

July 9, 1997

Virend superior to placebo for topical treatment of genital herpes in AIDS patients

July 8, 1997

AmBisome NDA to be discussed at Antiviral Drugs Advisory Committee meeting

July 8, 1997

Antimalarial agents from Roche

July 7, 1997

Promising preliminary phase II results obtained for Protovir in bone marrow transplant patients

July 3, 1997

Antimicrobial/cytotoxic compound isolated from fungal strain by Boehringer Mannheim

July 3, 1997

Abelcet approved in Canada

July 2, 1997

Sequus signs marketing agreement for Amphocil

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...